0056
Evaluating pCR after neoadjuvant systemic treatment of invasive breast cancer using DWI in comparison to DCE-based kinetic analysis
Rie Ota1, Masako Kataoka1, Maya Honda1, Mami Iima1, Kanae Kwai Miyake1, Akane Ohashi2, Yosuke Yamada3, Masakazu Toi4, and Yuji Nakamoto1
1Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University graduate school of medicine, Kyoto, Japan, 2Kyoto Medical Center, Kyoto, Japan, 3Department of Pathology, Kyoto University Hospital, Kyoto, Japan, 4Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan
DWI-based scoring system can be used to evaluate pCR with diagnostic performance similar to that in kinetic analysis, particularly in triple negative subtypes.

-ROC analysis for diagnosing pCR based on DWI score/Kinetic score-

Kinetic score showed slightly higher AUC while 95% confidence interval overlapped with that of DWI score. Both kinetic score and DWI score demonstrated excellent diagnostic performance among triple negative subtype compared to other subtype with AUC of 0.88-0.95. For luminal subtype, DWI score tended to perform better than kinetic score.

-Image evaluation-

  • DWI score

DWI of the target lesion was evaluated and categorized as 3-point scale.

0: no abnormal signal, 1: small focus of high - intermediate signal intensity, 2: obvious high signal intensity.

  • Kinetic score

Kinetic patterns of the lesions on DCE-MRI was scored as

0 : no enhancement, 1 : persistent, 2 : plateau and 3 : washout.

For both scores Low score indicates pCR.